Percutaneous Treatment of Hydatid Liver Cyst

Author(s): Antonio Giorgio, Antonella Di Sarno, Giorgio de Stefano, Nunzia Farella, Paolo Matteucci, Umberto Scognamiglio, Valentina Giorgio

Journal Name: Recent Patents on Anti-Infective Drug Discovery
Continued as Recent Advances in Anti-Infective Drug Discovery

Volume 4 , Issue 1 , 2009

Become EABM
Become Reviewer
Call for Editor


Percutaneous treatment of Hydatid Liver Cyst (HLC) with scolicidal agent under ultrasound guidance is now worldwide used after the advent of Percutaneous-Aspiration-Injection and Re-Aspiration (PAIR) and its modifications. Although HLC represent a benign disease, treatment has to be considered mandatory in symptomatic cysts and recommended in viable cysts because of the risk of severe complications. In this article, clinical indications, PAIR technique with results and complications are discussed. Finally, clinical flow-chart of active and inactive HLCs is reported. The present article is a review of some patents in the Hydatid liver cyst.

Keywords: Liver, interventional ultrasound, hydatid liver cyst, percutaneous-aspiration-injection and re-aspiration (PAIR), double-percutaneous-aspiration-and ethanol injection (D-PAI)

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Published on: 01 March, 2012
Page: [29 - 36]
Pages: 8
DOI: 10.2174/157489109787236274

Article Metrics

PDF: 24